HUP9802766A2 - Eljárás triazolszármazékok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei - Google Patents
Eljárás triazolszármazékok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjeiInfo
- Publication number
- HUP9802766A2 HUP9802766A2 HU9802766A HUP9802766A HUP9802766A2 HU P9802766 A2 HUP9802766 A2 HU P9802766A2 HU 9802766 A HU9802766 A HU 9802766A HU P9802766 A HUP9802766 A HU P9802766A HU P9802766 A2 HUP9802766 A2 HU P9802766A2
- Authority
- HU
- Hungary
- Prior art keywords
- compound
- general formula
- carbon
- preparation
- alkyl
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000002576 ketones Chemical class 0.000 title 1
- 125000002524 organometallic group Chemical group 0.000 title 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052740 iodine Chemical group 0.000 abstract 2
- -1 1- 3-pyrimidinyl pyrimidinyl Chemical group 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
A találmány tárgya eljárás (I) általánős képletű vegyület vagysavaddíciós, vagy bázikűs sója előllítására, ahől R jelentése adőtt esetben 1-3-szőr egymástól függetlenül halőgénatőmmalvagy triflűőr-metilcsőpőrttal szűbsztitűált fenilcsőpőrt, R1 jelentése 1-6 szénatőmős alkilcsőpőrt és Het jelentése adőtt esetben 1-3-szőr egymástól függetlenül 1-4 szénatőmősalkil-, 1-4 szénatőmős alkőxicsőpőrttal, halőgénatőmmal, őxő-, benzil-és/vagy benzilőxicsőpőrttal szűbsztitűált pirimidinil-csőpőrt, őly módőn, hőgy egy (II) általánős képletű vegyületet, ahől Rjelentése a fenti, (III) általánős képletű vegyülettel, ahől R1 és Hetjelentése a fenti és X klór-, bróm- vagy jódatőm, reagáltatják, cink,jód és/vagy Lewis-sav és egy aprőtikűs szerves őldószer jelenlétében,majd kívánt esetben az (I) általánős képletű vegyületet savaddíciósvagy bázikűs sóvá alakítják. A bejelentés vőnatkőzik még a fenti eljárásban kiindűlási anyagkéntalkalmazható, új, (III) általánős képletű vegyületre is. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9516121.2A GB9516121D0 (en) | 1995-08-05 | 1995-08-05 | Organometallic addition to ketones |
PCT/EP1996/003376 WO1997006160A1 (en) | 1995-08-05 | 1996-07-26 | Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9802766A2 true HUP9802766A2 (hu) | 1999-02-01 |
HUP9802766A3 HUP9802766A3 (en) | 2000-03-28 |
HU224339B1 HU224339B1 (hu) | 2005-08-29 |
Family
ID=10778850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9802766A HU224339B1 (hu) | 1995-08-05 | 1996-07-26 | Eljárás triazolok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei |
Country Status (32)
Country | Link |
---|---|
US (2) | US6586594B1 (hu) |
EP (1) | EP0871625B1 (hu) |
JP (3) | JP3211965B2 (hu) |
KR (1) | KR100269048B1 (hu) |
CN (1) | CN1076019C (hu) |
AR (1) | AR003472A1 (hu) |
AT (1) | ATE256679T1 (hu) |
AU (1) | AU703337B2 (hu) |
BR (1) | BR9609960A (hu) |
CA (1) | CA2228655C (hu) |
CZ (1) | CZ296975B6 (hu) |
DE (1) | DE69631160T2 (hu) |
DK (1) | DK0871625T3 (hu) |
EG (1) | EG21200A (hu) |
ES (1) | ES2210382T3 (hu) |
GB (1) | GB9516121D0 (hu) |
HK (1) | HK1014944A1 (hu) |
HU (1) | HU224339B1 (hu) |
IL (2) | IL131521A (hu) |
IN (1) | IN190817B (hu) |
MX (1) | MX9801025A (hu) |
MY (1) | MY123062A (hu) |
NO (1) | NO314938B1 (hu) |
NZ (1) | NZ315651A (hu) |
PE (1) | PE16897A1 (hu) |
PL (1) | PL187227B1 (hu) |
PT (1) | PT871625E (hu) |
RU (1) | RU2156760C2 (hu) |
TR (1) | TR199800170T1 (hu) |
TW (1) | TW442480B (hu) |
WO (1) | WO1997006160A1 (hu) |
ZA (1) | ZA966587B (hu) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7193083B2 (en) * | 1996-07-26 | 2007-03-20 | Pfizer, Inc. | Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
ES2337782T3 (es) | 2002-07-29 | 2010-04-29 | Rigel Pharmaceuticals, Inc. | Metodos para tratar o prevenir enfermedades autoinmunitarias con compuestos de 2,4-pirimidindiamina. |
BRPI0413018B8 (pt) * | 2003-07-30 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, e, uso de um composto |
WO2006028833A1 (en) * | 2004-09-01 | 2006-03-16 | Rigel Pharmaceuticals, Inc. | Synthesis of 2,4-pyrimidinediamine compounds |
WO2006068770A1 (en) | 2004-11-24 | 2006-06-29 | Rigel Pharmaceuticals, Inc. | Spiro-2, 4-pyrimidinediamine compounds and their uses |
CA2590687C (en) * | 2004-12-14 | 2013-09-10 | Dr. Reddy's Laboratories Ltd. | Process for preparing voriconazole |
WO2007027238A2 (en) * | 2005-05-03 | 2007-03-08 | Rigel Pharmaceuticals, Inc. | Jak kinase inhibitors and their uses |
US8143397B2 (en) | 2006-02-01 | 2012-03-27 | Medichem S.A. | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof |
AR061889A1 (es) | 2006-07-13 | 2008-10-01 | Medichem Sa | Proceso mejorado para la preparacion de voriconazol |
CN1919846B (zh) * | 2006-09-14 | 2013-01-02 | 大道隆达(北京)医药科技发展有限公司 | 伏立康唑及其药用盐、中间体的一种新定向合成制备方法 |
KR100889937B1 (ko) | 2007-08-06 | 2009-03-20 | 한미약품 주식회사 | 보리코나졸의 제조방법 |
GB2452049A (en) * | 2007-08-21 | 2009-02-25 | Alpharma Aps | Process for the preparation of voriconazole |
WO2009084029A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol |
CN101575330B (zh) * | 2008-05-05 | 2012-10-31 | 丽珠医药集团股份有限公司 | 伏立康唑广谱抗真菌药物化合物、其组合物及用途 |
US20110312977A1 (en) * | 2009-02-17 | 2011-12-22 | Glenmark Generics Limited | Process for the preparation of voriconazole |
KR101109215B1 (ko) * | 2009-06-17 | 2012-01-30 | 보령제약 주식회사 | 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법 |
MTP4285B (en) | 2009-12-30 | 2011-07-04 | Medichem Sa | A 1-(1h-1,2,3-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1, 2, 4- triazol-1yl) butan-2-ol derivative with substially undefined crystal shap for preparing said 1-(1h-1, 2, 4-triazol-1-yl0 butan-2-ol derivative |
KR100971371B1 (ko) | 2010-02-04 | 2010-07-20 | 동국제약 주식회사 | 신규한 중간체를 이용한 보리코나졸의 제조방법 |
WO2011110198A1 (en) | 2010-03-10 | 2011-09-15 | Synthron B.V. | A process for making voriconazole |
CN102344441B (zh) * | 2010-07-25 | 2015-05-06 | 浙江华海药业股份有限公司 | 一种制备伏立康唑中间体的工艺改进方法 |
CN101914091B (zh) * | 2010-07-25 | 2015-05-27 | 浙江华海药业股份有限公司 | 一种制备伏立康唑中间体的方法 |
EP2678333B1 (en) * | 2011-02-21 | 2015-04-08 | Ranbaxy Laboratories Limited | An improved process for the preparation of voriconazole and intermediates thereof |
KR101731155B1 (ko) | 2011-06-15 | 2017-04-27 | 신톤 비.브이. | 안정화된 보리코나졸 조성물 |
CN102516233B (zh) * | 2011-12-09 | 2014-04-09 | 北京联本医药化学技术有限公司 | 生产伏立康唑的方法 |
GR1007802B (el) * | 2012-01-31 | 2013-01-18 | Φαρματεν Αβεε, | Μεθοδος για την παρασκευη παραγωγου της βρωμοπυρινιδινης |
ES2615743T3 (es) | 2012-10-15 | 2017-06-08 | Pfizer Ireland Pharmaceuticals | Procedimiento de preparación de voriconazol y análogos de los mismos |
KR101435741B1 (ko) | 2013-01-17 | 2014-08-29 | (주) 에프엔지리서치 | 신규한 보리코나졸 중간체 및 이를 이용한 보리코나졸의 제조 방법 |
CN105503834B (zh) * | 2015-12-23 | 2021-03-05 | 浙江华海药业股份有限公司 | 一种伏立康唑中间体的合成方法 |
CN106432198B (zh) | 2016-09-08 | 2022-10-21 | 浙江华海药业股份有限公司 | 一种制备伏立康唑拆分中间体的方法 |
CN106632267B (zh) * | 2016-11-09 | 2019-02-22 | 中国科学院成都生物研究所 | 一种伏立康唑的合成方法 |
CN108276310A (zh) * | 2017-01-06 | 2018-07-13 | 常州齐晖药业有限公司 | 一种伏立康唑拆分剂(r)-10-樟脑磺酸的回收方法 |
CN108586433A (zh) * | 2017-07-21 | 2018-09-28 | 齐鲁工业大学 | 具有抗菌活性的伏立康唑盐酸盐 |
CN109705102A (zh) | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | 伏立康唑及其中间体的制备方法 |
CN110305113A (zh) * | 2019-07-05 | 2019-10-08 | 镇江市第四人民医院(镇江市妇幼保健院) | 一种伏立康唑杂质b的合成方法 |
CN112442017A (zh) * | 2019-08-29 | 2021-03-05 | 珠海润都制药股份有限公司 | 一种采用微通道反应器制备伏立康唑消旋体的方法 |
CN110724130A (zh) * | 2019-11-29 | 2020-01-24 | 怀化学院 | 伏立康唑及其中间体的合成方法 |
CN111440152B (zh) * | 2020-05-18 | 2022-09-27 | 浙江诚意药业股份有限公司 | 一种伏立康唑的制备方法 |
CN112079819B (zh) * | 2020-09-24 | 2022-06-17 | 南京易亨制药有限公司 | 一种改进的伏立康唑消旋体制备方法 |
CN112645935A (zh) * | 2020-12-15 | 2021-04-13 | 植恩生物技术股份有限公司 | 伏立康唑关键中间体的制备方法 |
CN115724829A (zh) * | 2022-12-23 | 2023-03-03 | 天津力生制药股份有限公司 | 一种分离真菌药物中间体杂质的液相色谱制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8819308D0 (en) | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Triazole antifungal agents |
GB9002375D0 (en) * | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
DE69500091T2 (de) * | 1994-02-01 | 1997-05-15 | Ube Industries | 4-Phenylamino-Pyrimidin-Derivate, Verfahren zur Herstellung und diese enthaltende Schädlingsbekämpfungsmittel für Landwirtschaft und Gartenbau |
-
1995
- 1995-08-05 GB GBGB9516121.2A patent/GB9516121D0/en active Pending
-
1996
- 1996-07-13 TW TW085108523A patent/TW442480B/zh not_active IP Right Cessation
- 1996-07-26 TR TR1998/00170T patent/TR199800170T1/xx unknown
- 1996-07-26 JP JP50809797A patent/JP3211965B2/ja not_active Expired - Lifetime
- 1996-07-26 BR BR9609960A patent/BR9609960A/pt not_active IP Right Cessation
- 1996-07-26 DE DE69631160T patent/DE69631160T2/de not_active Expired - Fee Related
- 1996-07-26 MX MX9801025A patent/MX9801025A/es not_active IP Right Cessation
- 1996-07-26 CZ CZ0032798A patent/CZ296975B6/cs not_active IP Right Cessation
- 1996-07-26 KR KR1019980700842A patent/KR100269048B1/ko not_active IP Right Cessation
- 1996-07-26 CN CN96196097A patent/CN1076019C/zh not_active Expired - Fee Related
- 1996-07-26 US US09/011,346 patent/US6586594B1/en not_active Expired - Fee Related
- 1996-07-26 WO PCT/EP1996/003376 patent/WO1997006160A1/en active IP Right Grant
- 1996-07-26 CA CA002228655A patent/CA2228655C/en not_active Expired - Fee Related
- 1996-07-26 DK DK96927644T patent/DK0871625T3/da active
- 1996-07-26 IL IL13152196A patent/IL131521A/en not_active IP Right Cessation
- 1996-07-26 IL IL12246296A patent/IL122462A/en not_active IP Right Cessation
- 1996-07-26 AU AU67403/96A patent/AU703337B2/en not_active Ceased
- 1996-07-26 AT AT96927644T patent/ATE256679T1/de not_active IP Right Cessation
- 1996-07-26 ES ES96927644T patent/ES2210382T3/es not_active Expired - Lifetime
- 1996-07-26 NZ NZ315651A patent/NZ315651A/xx unknown
- 1996-07-26 EP EP96927644A patent/EP0871625B1/en not_active Expired - Lifetime
- 1996-07-26 RU RU98103373/04A patent/RU2156760C2/ru not_active IP Right Cessation
- 1996-07-26 PT PT96927644T patent/PT871625E/pt unknown
- 1996-07-26 PL PL96324922A patent/PL187227B1/pl not_active IP Right Cessation
- 1996-07-26 HU HU9802766A patent/HU224339B1/hu not_active IP Right Cessation
- 1996-07-31 IN IN1707DE1996 patent/IN190817B/en unknown
- 1996-08-01 AR ARP960103831A patent/AR003472A1/es active IP Right Grant
- 1996-08-01 PE PE1996000578A patent/PE16897A1/es not_active Application Discontinuation
- 1996-08-02 ZA ZA9606587A patent/ZA966587B/xx unknown
- 1996-08-03 MY MYPI96003196A patent/MY123062A/en unknown
- 1996-08-04 EG EG73196A patent/EG21200A/xx active
-
1998
- 1998-02-02 NO NO19980441A patent/NO314938B1/no not_active IP Right Cessation
-
1999
- 1999-01-07 HK HK99100036A patent/HK1014944A1/xx not_active IP Right Cessation
-
2000
- 2000-06-21 JP JP2000186089A patent/JP3224532B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-27 JP JP2001131297A patent/JP2001354670A/ja active Pending
-
2003
- 2003-02-19 US US10/368,928 patent/US6946555B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802766A2 (hu) | Eljárás triazolszármazékok előállítására fémorganikus vegyületek ketonokhoz történő adagolásával és a vegyületek intermedierjei | |
ATE92475T1 (de) | Verfahren zur herstellung von 4-benzoyl-5hydroxypyrazolen. | |
KR840005719A (ko) | 트리아졸 유도체의 제조방법 | |
HUP9902473A2 (hu) | Új eljárások peszticid hatású vegyületek intermedierjeinek előállítására | |
KR850001184A (ko) | 1,5-벤조티아제핀 유도체의 제조방법 | |
ATE71621T1 (de) | Substituierte azolylethanolderivate als pflanzenwachstumsregulatoren. | |
ATE10838T1 (de) | 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. | |
DE69430667T2 (de) | Verfahren zur herstellung von fluoralkenylthio heterozyclische derivate | |
FR2430420A1 (fr) | Nouvelles morphinane-6-ones a substituant 8b-alkyle utiles comme intermediaires chimiques | |
KR100411410B1 (ko) | 2-(치환된벤조일)-1,3싸이클로헥산디온의제조방법 | |
DK0873327T3 (da) | Fremgangsmåde til fremstilling af 2-chlor-5-chlormethyl-thiazol | |
KR890014553A (ko) | 2α-메틸-2β-(1,2,3-트리아졸-1-일)메틸펜암-3α-카르복실산 유도체의 제조방법 | |
HUP0003059A2 (hu) | Eljárás 2-alkiltiobenzoesav-származékok előállítására | |
HUP9802863A2 (hu) | Eljárás difenil-éter-vegyületek nitrálására | |
IL56507A (en) | (trihalomethyl)dimethyloxabicyclohexanone derivatives for the preparation of cis dihalovinyldimethylcyclopropanecarboxylic acids | |
NO169076C (no) | Anhydrider av 1-ethyl-6-fluor-7-klor-4-oxo-1,4-dihydro-kinolin-3-carboxylsyre og borsyrer | |
KR860002474A (ko) | 치환된 페닐술포닐아졸의 제조방법 | |
FI873097A0 (fi) | Foerfarande foer framstaellning av 1-metylaminokinolin-karboxylsyraderivat. | |
DE69412085D1 (de) | Neues verfahren zur herstellung von beta-alkoxyacrylsäure | |
KR880011087A (ko) | 제초제 | |
GB1441718A (en) | Polyhalogenated propen-2-yl benzenes | |
CZ308994A3 (en) | Process for preparing 2,4,5-tribromopyrrole-3-carbonitril | |
DE69733716D1 (de) | Verfahren zur herstellung von imidazolderivaten | |
HUP0003321A2 (hu) | Eljárás 2-alkiltiobenzonitril-származékok előállítására | |
KR850004758A (ko) | 피라졸로 피리딘 유도체의 제법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HFG4 | Patent granted, date of granting |
Effective date: 20050620 |
|
GB9A | Succession in title |
Owner name: PFIZER IRELAND PHARMACEUTICALS, IE Free format text: FORMER OWNER(S): PFIZER RESEARCH AND DEVELOPMENT COMPANY, NV/S.A., IE |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |